Results 141 to 150 of about 7,028 (198)

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study. [PDF]

Adv Ther
Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A, Italian Network for Inflammatory Bowel Diseases (IN-IBD).   +62 more
europepmc   +1 more source

Real-world efficacy of oral upadacitinib for vitiligo and factors associated with treatment response: A retrospective study. [PDF]

JAAD Int
Liu Y, Shi X, Yuan Y, Sun R, Du J, Wang F, Ding X.   +6 more
europepmc   +1 more source

Clinical outcomes of upadacitinib dose escalation in inflammatory bowel disease: A single-center retrospective cohort study. [PDF]

World J Gastrointest Pharmacol Ther
Ellington AL, Rambuss D, Barbina S, Chitnavis M.   +3 more
europepmc   +1 more source

Upadacitinib therapy for foreign body granuloma induced by facial fillers. [PDF]

An Bras Dermatol
Duan M, Wu Y, Shen H, Dai Y.
europepmc   +1 more source

Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure. [PDF]

J Clin Gastroenterol
Lee SD, Kamp KJ, Jacobs J, Harper J, Barahimi M, Clark-Snustad KD.   +5 more
europepmc   +1 more source

Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis. [PDF]

Allergy Asthma Immunol Res
Park SY, Heo SJ, Gwag HE, Hong N, Kook HD, Jung HJ, Park MY, Ahn J.   +7 more
europepmc   +1 more source

Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitis. [PDF]

Nat Commun
Liu B, Spalinger MR, Invernizzi A, Gerdes E, Steglich B, Schwarzfischer M, Machicote A, Pelczar P, Pöhlmann D, Nawrocki M, Böttcher M, Aleko A, Velasquez LN, Wende S, Stallbaum F, Neuendorff J, Grosshauser S, Muscate F, Douilhet G, Perez LG, Sabihi M, Möller K, Viehweger F, Sutter JP, Kilian C, Kumar Y, Fründt T, Sauter G, Rösch T, Gagliani N, Caflisch A, Scharl M, Huber S.   +32 more
europepmc   +1 more source

Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD). [PDF]

Open Access Rheumatol
Almoallim HM, Bahlas SM, Bawazir Y, Hussein AH, Attia GM, Manasfi H, Bafadhl ZA, Asiri AM, Ali AR, Alomair MM, Alsharaif MM, Almalki HH, Siddiqui MI, Alhazmi AS, Attar SM.   +14 more
europepmc   +1 more source

Case Report: Successful treatment of SAPHO syndrome refractory to adalimumab with upadacitinib. [PDF]

Front Immunol
Du J, Li Y, Geng S, Li C, Shang S.
europepmc   +1 more source

Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. [PDF]

Acta Derm Venereol
Andersen YMF, Seyed-Alinaghi F, Kristiansen MF, Thomsen SF.   +3 more
europepmc   +1 more source